Published in J Gastroenterol on October 31, 2015
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet (2008) 10.87
Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med (2011) 10.33
Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet (2005) 6.85
The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology (2010) 2.75
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol (2014) 2.55
Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B. Hepatology (2014) 2.19
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One (2012) 1.56
A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. J Hepatol (2014) 1.52
Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology (2011) 1.52
Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis. Am J Gastroenterol (2013) 1.48
Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J Biol Chem (1992) 1.45
Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology (2013) 1.04
Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals. Diabetologia (2009) 1.02
The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. J Gastroenterol (2012) 0.91
The role of JAZF1 on lipid metabolism and related genes in vitro. Metabolism (2010) 0.88
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C. J Gastroenterol (2013) 0.88
HUMAN MAMMARY SLICES IN ORGAN CULTURE. I. METHOD OF CULTURE AND PRELIMINARY OBSERVATIONS ON THE EFFECT OF INSULIN. Exp Cell Res (1964) 0.84
The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. J Gastroenterol (2015) 0.81
The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey. J Gastroenterol (2014) 0.79
Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy (2013) 1.19
A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Hepatology (2015) 0.83
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. J Gastroenterol (2015) 0.81
A successful case of deceased donor liver transplantation for a patient with intrahepatic arterioportal fistula. Hepatol Res (2016) 0.80
Biphasic effect of alcohol intake on the development of fatty liver disease. J Gastroenterol (2015) 0.79
Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis. Hepatol Res (2014) 0.75
Simultaneous occurrence of gastric lipoma and early gastric cancer. Endoscopy (2014) 0.75
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy. Sci Rep (2022) 0.75
Spur cells and acanthocytes in liver diseases. Hepatol Res (2007) 0.75
Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res (2017) 0.75